Sentence examples for intermediate medium from inspiring English sources

(d) The percentage of CpGs with coverage ranging from 5X to 20X that have methylation = 0 (light), intermediate (medium), or = 1 (dark) for proliferating bulk and arrested samples.

The vadose zone is the intermediate medium between the atmosphere and groundwater.

At each step, the behavior of intermediate medium is obtained by any analytical homogenization method and is used as matrix of the following step.

(h) For proliferating and arrested ESCs: the proportion of CpGs that overlap with GATA6 binding sites in mesoderm, EOMES binding sites in mesendoderm and OCT4 binding sites in ESCs that have methylation = 0 (light), intermediate (medium) or = 1 (dark) are displayed.

The effects of different key parameters on the heat transfer performance of the HCHE are investigated, such as inlet temperature, velocity of intermediate medium, pipe length and diameter, temperature of seawater and icing outside the pipes.

The combustion gases and the working fluid (clean air) flow separately in the two columns, and ceramic particles are employed as solid intermediate medium to transfer heat between the two columns.

This guide grades the repertoire in terms of easy, intermediate, medium-difficult and difficult, along with comments about technical requirements.

The so-called microconvex probe is an intermediate medium-high frequency probe, which couples: the good image resolution of a high frequency (usually linear in shape) probe, required for venepuncture guidance; the scanning depth (up to 10-12 cm and more) of a medium-frequency (usually convex in shape) one, required for rule-out of pleural complications, i.e. pneumothorax and fluid collections.

In contrast, for the intermediate (medium-wavelength sensitive) region most of the variation was at low taxonomic levels; between species within the same family (Figure 3).

Major adverse cardiovascular events occurred in patients of all groups, except the low-dose group; however, incidences in the intermediate-, medium- and high-dose groups were lower versus the placebo group (0.19%, 0.44% and 0.23% versus 0.53% per month, respectively).

The IR of thrombocytopenia AEs were higher across all canakinumab groups (1.04%, 0.46%, 0.56% and 0.46% per month in low-, intermediume-, medium- and high-dose groups, respectively) compared with placebo (0.23% per month).